SCH-23390 maleate

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

SCH-23390 maleate

Specification
Cat. No.
SMD1179
Related Diseases
Depression
Product Name
SCH-23390 maleate
Size
50.0mg; 100.0mg; 200.0mg; 500.0mg; 1.0g; 2.0g
Price
Inquiry
Availability
2 Weeks
Description
SCH-23390 hydrochloride is a potent dopamine receptor antagonist (Ki values are 0.2 nM and 0.3 nM at D1 and D5 receptor sub-types, respectively). SCH-23390 hydrochloride is also an agonist at 5-HT1C and 5-HT2C receptors in vitro (Ki values are 6.3 nM and 9.3 nM respectively). It blocks quinpirole-induced Kir3 (GIRK) currents (EC50 = 268 nM) independently of receptors.
CAS Number
87134-87-0 (maleate)
Chemical Formula
C21H22ClNO5
Molecular Weight
403.859
Elemental Analysis
C, 62.46; H, 5.49; Cl, 8.78; N, 3.47; O, 19.81
Synonym
SCH-23390; SCH23390; SCH 23390; SCH-23390 maleate;
IUPAC/Chemical Name
(R)-8-chloro-3-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol maleate
InChi Key
FGHVSEXHEAUJBT-HFNHQGOYSA-N
InChi Code
InChI=1S/C17H18ClNO.C4H4O4/c1-19-8-7-13-9-16(18)17(20)10-14(13)15(11-19)12-5-3-2-4-6-12;5-3(6)1-2-4(7)8/h2-6,9-10,15,20H,7-8,11H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t15-;/m1./s1
SMILES Code
OC1=C(Cl)C=C2CCN(C)C[C@H](C3=CC=CC=C3)C2=C1.O=C(O)/C=C\C(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top